Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Yuji Niu"'
Autor:
Lin Zhou, Wenwen Gu, Fuguang Kui, Fan Gao, Yuji Niu, Wenwen Li, Yaru Zhang, Lijuan Guo, Junru Wang, Zhenzhen Guo, Gangjun Du
Publikováno v:
Food & Nutrition Research, Vol 65, Pp 1-14 (2021)
Background: Chronic obstructive pulmonary disease (COPD) is an important risk factor for developing lung cancer. Aged citrus peel (chenpi) has been used as a dietary supplement for respiratory diseases in China. Objective: To explore the mechanism an
Externí odkaz:
https://doaj.org/article/e77e78cc35be47dfb35d8d3cb7a6db6d
Autor:
Yuehua Wang, Wenwen Gu, Fuguang Kui, Fan Gao, Yuji Niu, Wenwen Li, Yaru Zhang, Zhenzhen Guo, Gangjun Du
Publikováno v:
Food & Nutrition Research, Vol 65, Iss 0, Pp 1-17 (2021)
Background: Coronavirus disease 2019 (COVID-19) outbreak is progressing rapidly, and poses significant threats to public health. A number of clinical practice results showed that traditional Chinese medicine (TCM) plays a significant role for COVID-1
Externí odkaz:
https://doaj.org/article/3e9b24de91d94f39b3e31c642f7b71fc
Autor:
Wenwen Gu, Mengdi Zhang, Fan Gao, Yuji Niu, Luyao Sun, Haojie Xia, Wenwen Li, Yaru Zhang, Zhenzhen Guo, Gangjun Du
Publikováno v:
International Immunopharmacology. :110366
Autor:
Zhenzhen Guo, Wenwen Gu, Yuji Niu, Yuehua Wang, Fuguang Kui, Wenwen Li, Yaru Zhang, Gangjun Du, Fan Gao
Publikováno v:
Food & Nutrition Research, Vol 65, Iss 0, Pp 1-17 (2021)
Food & Nutrition Research
Food & Nutrition Research
Background: Coronavirus disease 2019 (COVID-19) outbreak is progressing rapidly, and poses significant threats to public health. A number of clinical practice results showed that traditional Chinese medicine (TCM) plays a significant role for COVID-1
Autor:
Wenwen, Gu, Mengdi, Zhang, Fan, Gao, Yuji, Niu, Luyao, Sun, Haojie, Xia, Wenwen, Li, Yaru, Zhang, Zhenzhen, Guo, Gangjun, Du
Publikováno v:
International Immunopharmacology. 110:108965
Coptis chinensis Franch (CCF) has been widely used by Chinese old herbalist doctor to treat internal and external diseases including malignant sore and cancer. Berberine (BBR) is a major bioactive compound in CCF and may exert anti-tumor and anti-inf
Autor:
Zhenzhen Guo, Gangjun Du, Lin Zhou, Fan Gao, Wenwen Gu, Yuji Niu, Yaru Zhang, Lijuan Guo, Fuguang Kui, Junru Wang, Wenwen Li
Publikováno v:
Food & Nutrition Research, Vol 65, Pp 1-14 (2021)
Background Chronic obstructive pulmonary disease (COPD) is an important risk factor for developing lung cancer. Aged citrus peel (chenpi) has been used as a dietary supplement for respiratory diseases in China. Objective To explore the mechanism and
Autor:
Peng, Xi, Yuji, Niu, Yaru, Zhang, Wenwen, Li, Fan, Gao, Wenwen, Gu, Fuguang, Kui, Zhongqiu, Liu, Linlin, Lu, Gangjun, Du
Publikováno v:
Journal of Ethnopharmacology. 292:115138
Dioscorea nipponica Makino as a Chinese folk medicine has been used for the treatment of chronic bronchitis, cough, and asthma. Several studies have established the antimetastatic potential of Dioscorea nipponica Makino extract. Dioscin is a major bi
Autor:
Lijuan Guo, Shihong Cen, Yaru Zhang, Fuguang Kui, Zhenzhen Guo, Wenwen Li, Wenwen Gu, Yuji Niu, Gangjun Du, Junru Wang, Fan Gao
Publikováno v:
Evidence-Based Complementary and Alternative Medicine, Vol 2021 (2021)
Evidence-based Complementary and Alternative Medicine : eCAM
Evidence-based Complementary and Alternative Medicine : eCAM
Xuefu Zhuyu Decoction (XFZY) is an ancient compound widely used in the treatment of coronary heart disease. However, its efficacy evaluation is not complete and its mechanism of action is not clear enough. In an attempt to address these problems, the
Autor:
Shengnan Geng, Fan Gao, Wenwen Gu, Yuji Niu, Fuguang Kui, Lijuan Guo, Yaru Zhang, Gangjun Du, Wenwen Li, Mengqi Wang
Publikováno v:
Evidence-Based Complementary and Alternative Medicine, Vol 2021 (2021)
Evidence-based Complementary and Alternative Medicine : eCAM
Evidence-based Complementary and Alternative Medicine : eCAM
This work is carried out to evaluate the clinical efficacy of Sanzi Yangqin decoction (SZYQD) treating chronic obstructive pulmonary disease (COPD) and to analyze its mechanism. The clinical efficacy of SZYQD treating COPD was evaluated by meta-analy